Ronald Andrews

2020

In 2020, Ronald Andrews earned a total compensation of $1M as President and Chief Executive Officer at Oncocyte Corp, a 49% decrease compared to previous year.

Compensation breakdown

Bonus$465,600
Change in Pension Value and Nonqualified Deferred Compensation Earnings$9,190
Option Awards$68,500
Salary$487,385
Other$16,175
Total$1,046,850

Andrews received $487.4K in salary, accounting for 47% of the total pay in 2020.

Andrews also received $465.6K in bonus, $9.2K of change in pension value and nonqualified deferred compensation earnings, $68.5K in option awards and $16.2K in other compensation.

Rankings

In 2020, Ronald Andrews' compensation ranked 8,428th out of 13,090 executives tracked by ExecPay. In other words, Andrews earned more than 35.6% of executives.

ClassificationRankingPercentile
All
8,428
out of 13,090
36th
Division
Manufacturing
3,582
out of 5,621
36th
Major group
Chemicals And Allied Products
1,451
out of 2,254
36th
Industry group
Drugs
1,263
out of 1,954
35th
Industry
In Vitro and In Vivo Diagnostic Substances
30
out of 60
50th
Source: SEC filing on May 21, 2021.

Andrews' colleagues

We found three more compensation records of executives who worked with Ronald Andrews at Oncocyte Corp in 2020.

2020

Albert Parker

Oncocyte Corp

Chief Operating Officer

2020

Mitchell Levine

Oncocyte Corp

Chief Financial Officer

2020

Padma Sundar

Oncocyte Corp

Senior Vice President, Marketing and Market Access

News

You may also like